Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

PetVivo Holdings Inc provides update on Kush(TM) Study Results


Monday, 16 Jun 2014 07:04am EDT 

PetVivo Holdings Inc:To provide an update on the Kush study results for treating animal osteoarthritis.PetVivo has licensed the Kush device from Gel-Del Technologies, Inc. and is planning a launch in Q4 of this year.PetVivo CEO John Lai says Kush device, demonstrating great safety data for over eight years in five species, including people, case-study reports to treat bad joints in horses, started 3 years ago, and dogs, started 6 months ago, have been very positive. 

Company Quote

2.85
0.18 +6.74%
22 Oct 2014